These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36533339)

  • 1. [Relationship between anti-ENO1 antibody and systemic lupus erythematosus patients with retinopathy].
    Zhang LQ; Zhao J; Wang HY; Wang ZY; Li YN; Tang JY; Li SY; Qu JF; Zhao MW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1099-1105. PubMed ID: 36533339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and immunological characteristics of systemic lupus erythematosus with retinopathy].
    Li M; Hou LQ; Jin YB; He J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1106-1111. PubMed ID: 36533340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus.
    Sun J; Li X; Zhou H; Liu X; Jia J; Xie Q; Peng S; Sun X; Wang Q; Yi L
    J Immunol Res; 2019; 2019():7430780. PubMed ID: 31049359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-recoverin antibodies indicate fundus abnormalities in systemic lupus erythematosus.
    Li M; Cheng G; Wang Z; Liu W; Jin Y; Huang B; Wang Y; Qu J; Shi G; Su Y; He J; Li Z
    Lupus; 2020 Oct; 29(11):1346-1352. PubMed ID: 32703115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of anti-carbamylated fibrinogen antibodies in systemic lupus erythematosus].
    Li YN; Xiang XH; Zhao J; Li Y; Sun F; Wang HY; Jia RL; Hu FL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1019-1024. PubMed ID: 31848497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus.
    Shao M; Sun XL; Sun H; He J; Zhang RJ; Zhang X; Li ZG
    Chin Med J (Engl); 2018 Jul; 131(13):1520-1526. PubMed ID: 29941704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
    Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus retinopathy: a marker of active systemic lupus erythematosus.
    Seth G; Chengappa KG; Misra DP; Babu R; Belani P; Shanoj KC; Kumar G; Negi VS
    Rheumatol Int; 2018 Aug; 38(8):1495-1501. PubMed ID: 29948002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus erythematosus patients.
    Shi H; Ye J; Teng J; Yin Y; Hu Q; Wu X; Liu H; Cheng X; Su Y; Liu M; Gu J; Lu T; Chen H; Zheng H; Sun Y; Yang C
    Arthritis Res Ther; 2017 Mar; 19(1):52. PubMed ID: 28274252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up.
    Dai Y; Li E; Chen D; Niu X; Wang Z; Lu L; Zheng B
    Front Immunol; 2022; 13():913714. PubMed ID: 36189276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
    Zhou Z; Xu A; Teng J; Wang F; Tan Y; Liu H; Cheng X; Su Y; Shi H; Hu Q; Chi H; Li J; Hou J; Sun Y; Yang C; Ye J
    J Immunol Res; 2020; 2020():2180708. PubMed ID: 33224991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity.
    Li Y; Jia R; Liu Y; Tang S; Ma X; Shi L; Zhao J; Hu F; Li Z
    Lupus; 2020 Mar; 29(3):239-247. PubMed ID: 31930936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating group II phospholipase A2 activity and antilipocortin antibodies in systemic lupus erythematosus. Correlative study with disease activity.
    Pruzanski W; Goulding NJ; Flower RJ; Gladman DD; Urowitz MB; Goodman PJ; Scott KF; Vadas P
    J Rheumatol; 1994 Feb; 21(2):252-7. PubMed ID: 8182633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case report of systemic lupus erythematosus patient with severe lupus retinopathy and antiphospholipid antibody].
    Imanaka H; Takei S; Hukami S; Maeno N; Shigemori M; Hokonohara M; Miyata K
    Ryumachi; 1999 Feb; 39(1):22-6. PubMed ID: 10332213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
    Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
    J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
    Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; d'Alessandro M; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Volpi S; Mosca M; Tincani A; Candiano G; Prunotto M; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
    Rheumatology (Oxford); 2021 Jul; 60(7):3388-3397. PubMed ID: 33351137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal disease in patients with systemic lupus erythematosus.
    Ushiyama O; Ushiyama K; Koarada S; Tada Y; Suzuki N; Ohta A; Oono S; Nagasawa K
    Ann Rheum Dis; 2000 Sep; 59(9):705-8. PubMed ID: 10976084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of B cell-activating factor (BAFF) and anti-BAFF autoantibodies with disease activity in multi-ethnic Asian systemic lupus erythematosus patients in Singapore.
    Howe HS; Thong BYH; Kong KO; Chng HH; Lian TY; Chia FL; Tay KSS; Lau TC; Law WG; Koh ET; Leung BP
    Clin Exp Immunol; 2017 Sep; 189(3):298-303. PubMed ID: 28388832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.